TI Pharma

Scalable Life Sciences supported the Top Institute Pharma (TI Pharma) in the area of public affairs.

Top Institute Pharma (TI Pharma) is a public-private partnership in which scientific and business
worlds work together on groundbreaking, multidisciplinary research aimed at improving the development
of socially valuable medicines. The research portfolio is based on the disease areas as specified in
Priority Medicines, a report by the World Health Organization (WHO). The knowledge gained in these
projects provides an important contribution to better, faster and less-expensive development of valuable
new medicines.

Corporate Communications, Investor Relations and Public Affairs for Life Sciences